Emae Lee-Voritskul, CPA

Emae Lee-Voritskul, CPA has extensive work experience spanning over two decades. Emae'smost recent role is as Corporate Controller at Adaptive Phage Therapeutics beginning in 2022. Prior to this, they served as Director of SEC Reporting at Altimmune, Inc. from 2020 to 2022. From 2019 to 2020, Emae was an Assistant Controller at MESO SCALE DIAGNOSTICS, LLC. Emae held the position of Senior Manager, SEC Reporting & Accounting at Emergent BioSolutions from 2015 to 2019. Emae's previous roles include Manager, Financial Reporting at MedImmune, Inc. from 2005 to 2008, Senior Accountant, Financial Reporting/General Ledger at Human Genome Sciences from 2001 to 2005, and Senior Accountant, Financial Reporting at US Airways (now American Airlines) from 1999 to 2001. Emae began their career as an Auditor, Assurance and Advisory Business Services at EY from 1997 to 1999. Throughout their career, Emae has demonstrated their expertise in accounting, financial reporting, and SEC regulations.

Emae Lee-Voritskul, CPA holds a Bachelor of Science (BS) degree in Accounting from the University of Maryland - Robert H. Smith School of Business. Emae has also obtained the Certified Public Accountant (CPA) certification. However, specific details regarding when they obtained the certification and the institution from which they received it are not available.